In this study, miR-541 was found to be associated with the prognosis of liver cirrhosis and directly targets JAG2 to inhibit the activation of the Notch signaling pathway and HSCs, suggesting that this miRNA could serve as a novel non-invasive biomarker for prognosis prediction and therapeutic target for liver cirrhosis. Here, JAG2 is linked to cirrhosis of liver.